1
|
XXX-03115081
|
DO 25-2021 DECLARACION(2-3) PROTOCOLO ID-064A301. IMPORTACION PARCIAL INCLUYE AUTORIZACION DE DIVISION DE BULTOS No. 277
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-25
|
UNITED STATES
|
1 Kgs
|
7 U
|
2
|
XXX-03115081
|
DO 25-2021 DECLARACION(1-3) PROTOCOLO ID-064A301. IMPORTACION PARCIAL INCLUYE AUTORIZACION DE DIVISION DE BULTOS No. 277
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-25
|
UNITED STATES
|
4 Kgs
|
20 U
|
3
|
XXX-03115081
|
DO 25-2021 DECLARACION(3-3) PROTOCOLO ID-064A301, IMPORTACION PARCIAL INCLUYE AUTORIZACION DE DIVISION DE BULTOS No. 277
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-25
|
UNITED STATES
|
4 Kgs
|
2 U
|
4
|
XXX-03110179
|
DO 25-2137 DECLARACION(1-1) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-24-0100109 DE FECHA 2024-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-25
|
UNITED STATES
|
5 Kgs
|
66 U
|
5
|
XXX-03115248
|
DO 25-2020 DECLARACION(2-2) PROTOCOLO ID-064A301. VISTO BUENO INVIMA NO. VINVIMA-25-0060424 DE FECHA 2025-05-02. NO REEM
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-12
|
UNITED STATES
|
2 Kgs
|
11 U
|
6
|
XXX-03115248
|
DO 25-2020 DECLARACION(1-2) PROTOCOLO ID-064A301. VISTO BUENO INVIMA NO. VINVIMA-25-0043779 DE FECHA 2025-03-31. NO REEM
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-12
|
UNITED STATES
|
6 Kgs
|
43 U
|
7
|
XXX-03076357
|
DO 25-1951 DECLARACION(2-3) PROTOCOLO: ID-064A301, NO REEMBOLSABLE POR TRATARSE DE IMPORTACIONES PARA ESTUDIOS CLINICOS.
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-06
|
UNITED STATES
|
5 Kgs
|
2 U
|
8
|
XXX-03076357
|
DO 25-1951 DECLARACION(1-3) PROTOCOLO ID-064A301. VISTO BUENO INVIMA NO. VINVIMA-25-0043779 DE FECHA 2025-03-31. NO REEM
|
INTRIALS SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-06
|
UNITED STATES
|
3 Kgs
|
15 U
|
9
|
XXX-03109948
|
DO 25-1934 DECLARACION(3-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2), VISTO BUENO INVIMA NO. VINVIMA-24-0134661 DE FECHA 2024-1
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-06
|
UNITED STATES
|
26 Kgs
|
4 U
|
10
|
XXX-03109948
|
DO 25-1934 DECLARACION(1-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2), INCLUYE FACTURAS No. SO 134877 SO 134875 SO 132834 DE
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-06-06
|
UNITED STATES
|
0.27 Kgs
|
31 U
|